For patients with acute ischemic stroke (AIS), tenecteplase (TNK) has improved functional outcome and reduced disabi ...

New research shows young adults face large vessel occlusion strokes, once seen mostly in older adults, due to rising stroke ...

Tenecteplase is a third-generation thrombolytic agent that has a favourable pharmacological profile, compared with alteplase. Tenecteplase has a longer half-life, which allows administration in a ...

Although average ED boarding time fell from 182 minutes in 2022 to 110 minutes in 2023, boarding remains a challenge for high-volume EDs. For EDs that treat more than 80,000 patients annually, ...

Clinicians at Royal Papworth Hospital NHS Foundation Trust are using AI technology from Brainomix to deliver faster diagnoses of strokes.

Community EMS may contribute to improving oral health status by including oral health screenings in outreach efforts, ...

Transformative health tech solutions were at the heart of conversations at GITEX GLOBAL’s GITEX DIGI_HEALTH 5.0 Dubai, ...

ACTICOR BIOTECH, a clinical-stage biopharmaceutical company founded in 2013 from the work of INSERM, is developing glenzocimab, a humanized monoclonal antibody fragment (fab) targeting the GPVI ...

Innovators and leaders from the most influential medical labs, hospitals, healthcare institutions, research centres and ...

The Icahn School of Medicine has announced a $5 million gift from the John and Daria Barry Foundation for the Center for Ophthalmic Artificial Intelligence (AI) and Human Health.

In patients with COPD both with or without heart failure, AF episodes rise around the time patients are hospitalized for ...